Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-02

Clinical Trial Update: Phase I Study of Nicotinamide for Early Onset Preeclampsia [Phase 1]

View source ↗

Summary

Phase I trial assessing nicotinamide for early onset preeclampsia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (nicotinamide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pregnancy Induced Hypertension, Superimposed Preeclampsia | Phase 1 | Status: COMPLETED | Results posted: 2018-11-02